Open in interactive viewer → charts, metric popovers & call review

Indorama Ran a Two-Year Asset Review and Decided to Keep the Plants

Q3 EBITDA rose 65% on a mix of Iran-driven market luck and THB 17.4bn of self-help — but the headline is a strategic review that ended in retention, a European safeguard probe, and a leverage ratio still at 4.7x.
IVL.BK · Earnings Call · 2026-11-08

Indorama Ran a Two-Year Asset Review and Decided to Keep the Plants

For several quarters the market has been waiting on one answer from Indorama Ventures: which of the underperforming plants get sold? The strategic review covered three assets inside the combined PET segment — the IVOG/IVOL ethylene and EOEG complexes, the PTA/PIA site in Spain, and the Specialty Polymers portfolio. The implied trade was simple: sell the losers, keep the cash, pay down debt. Instead, management kept them.

“So as far as the integrated EG assets that we are now deciding to retain and continue to operate and improve.” — Muthukumar Paramasivam, Executive (likely in PET or Intermediate segment) · 2026-11-08

That is the story of this quarter, and it is a genuine reversal of direction relative to the portfolio actions narrative that has dominated recent calls. The justification is a blend of reliability engineering, a "Project Rebound" investment case, and — critically — the shale-to-PET feedstock advantage in the US. Management was candid that the plants have to earn above cost of capital, and equally candid that the capex number is not yet decided. That is a promise, not a proof.

The headline beat is part weather, part work

Nine-month EBITDA rose 63% to THB 43.5 billion on 5% lower sales volume, with the margin widening to 11% from 8%. Q3 alone was THB 13.7 billion, up 65% year-on-year. Guidance for the full year is now THB 54–56 billion, roughly 20% above the Capital Markets Day plan set earlier this year.

“9-month EBITDA increased 63% to THB 43.5 billion with 5% lower sales volume, that reflects stronger profitability per tonne, supported by market conditions and progress under our 5 enterprise priorities.” — Aloke Lohia, Chief Executive Officer · 2026-11-08

The problem with that sentence is its first clause. A large share of the improvement is favorable market conditions — the conflict-driven re-rating of local-for-local supply, MTBE and integrated EG spreads, and brand-owner restocking. Benchmark integrated PET spreads went from $113 to $176 per tonne; Intermediate Chemicals EBITDA went from THB 646 million to THB 3.3 billion. Management flagged the fade explicitly, guiding that conflict in Iran benefits will moderate and Indovinya will not repeat its strongest quarter.

What makes the quarter more than a spread windfall is the cost work. The fixed cost line has come down from THB 84 billion in 2023 to an estimated THB 74 billion for 2026 — a 12% cut despite three years of inflation, on a gross reduction of THB 17.4 billion. Ten manufacturing sites, four divestments and six rationalizations, 3.4 million tonnes of capacity.

We have taken approximately THB 35 billion of noncash impairments, which reflects the reduction in our carrying value for the assets. We have provided and spent around THB 5.5 billion in onetime cash expenses... The program has also reduced fixed costs by approximately THB 5.4 billion on an annual basis.

Ashok Jain, Chief Financial Officer · 2026-11-08

That is a real, recurring reduction in the base — the kind of thing that persists once spreads normalize. It also explains why the company can talk about a competitive footprint rather than just cost-cutting.

Europe: the hole that the review did not fill

The retained assets are, of course, the ones in the hardest geography. Europe remains the laggard: EMEA EBITDA of THB 4.4 billion for nine months is a recovery from roughly THB 0.9 billion, but the Fibers business swung to a THB 118 million quarterly loss as Q2 inventory benefits failed to repeat. Management named the drivers plainly — energy cost, Chinese competition, high fixed costs.

There is one genuinely new catalyst here, and it did not come from the company: the European Commission opened a safeguard investigation into the PET value chain, including PIA, in the week before the call.

“the initiation of a safeguard investigation last week by the European Commission on the PET value chain, including PIA, this is an important event contributing towards the future performance of the European region.” — Muthukumar Paramasivam, Executive (likely in PET or Intermediate segment) · 2026-11-08

Whether that becomes protection or just noise is unanswerable today, but it is the first trade-policy lever the European business has had in years.

The deleveraging arithmetic is the real proof

Strip out the narrative and Indorama's case rests on a single comparison. In 2022, crude rose 11% and working capital swelled, costing THB 2 billion of cash outflow. In 2026, crude rose 34% — and working capital fell THB 15 billion. Inventory turns improved from 4.5x to 5.3x against a 6x target.

“Our net debt to equity has decreased from 1.74x to 1.52x, while our net debt-to-EBITDA has decreased from 6.6x to 4.7x on last 12-month basis.” — Ashok Jain, Chief Financial Officer · 2026-11-08

Net debt sits at THB 223.7 billion, down THB 19.4 billion year-on-year, with operating cash flow after maintenance capex at 95% of EBITDA on a trailing basis. Financing costs fell from THB 3.6 billion to THB 3.1 billion a quarter, the blended rate from 5.7% to 5.1%. This is the lower debt flywheel management has promised for three years and is now visibly spinning — a theme with echoes elsewhere in the market, where debt reduction has become a recurring talking point among capital-intensive mid-caps.

But 4.7x is still 4.7x, and it flatters itself: that multiple includes a soft Q4 2025 in the denominator. The 2028 target of 3x or below is the number that matters, and the bridge to it leans on the India packaging consolidation (EPL, closing Q1 2027), which is supposed to nearly double Indovida's EBITDA.

What to watch

Three things will decide whether this was a good quarter or a good year. First, whether management's exposure discipline survives — Sunil Marwah called Q3 the first period where inventory gains and price lag losses genuinely offset, and the claim deserves scepticism until tested across a full down-cycle in crude. Second, whether the retained assets get the capex they need without a second round of impairments. Third, Europe: the fixed cost base is lower, but the revenue line still depends on energy and trade policy that Indorama does not control.

“we expect to realize cash of THB 6.6 billion in 2027, '28.” — Ashok Jain, Chief Financial Officer · 2026-11-08

The sale pipeline has slipped — management conceded delays — and the near-term cash is modest: THB 650 million from an airbag JV stake in Q4. So the deleveraging from here is mostly operating cash flow plus the oil price, not asset sales. The board meets this week on the dividend, with the CEO promising consistency. For a company that just chose retention over divestment, the dividend is the cheapest possible signal of confidence.